NOEL FERRER: Open Payments
NPI 1992065478 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,803 in 94 payments from 18 companies in 2025. Trend: 2023 $1,298 · 2024 $1,600 · 2025 $1,803
Food & beverage: $1,803
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $293 |
| ABBVIE INC. | 18 | $233 |
| Regeneron Healthcare Solutions, Inc. | 8 | $217 |
| UCB, Inc. | 13 | $191 |
| Galderma Laboratories, L.P. | 13 | $176 |
| Novartis Pharmaceuticals Corporation | 6 | $146 |
| LEO Pharma Inc. | 5 | $119 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $91 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $71 |
| Botanix SB Inc | 3 | $47 |
Products named: DUPIXENT, Bimzelx, RINVOQ, NEMLUVIO, ADBRY, Rhapsido, Winlevi, COSENTYX.
Industry payments across GA — which companies pay providers there.
